| Literature DB >> 8563509 |
T R Bai1.
Abstract
Inhaled glucocorticoids are currently an important part of asthma management. There is no evidence that the more recently introduced inhaled agents, which have high topical activity and low systemic bioavailability, are unsafe at doses below 2000 micrograms/d. The choice of the delivery device for inhaled glucocorticosteroids is as important as the choice of the particular drug.Entities:
Mesh：
Substances：
Year: 1995 PMID： 8563509 PMCID： PMC2146761
Source DB: PubMed Journal: Can Fam Physician ISSN： 0008-350X Impact factor: 3.275